logo
Login

BLISS GVS PHARMA LTD (BLISSGVS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.

BLISSGVSUpdated 1 Sept 2026, 1:43

Bliss Gvs Pharma Ltd

Market Cap

₹6,566Cr.

Current Price

₹617

High / Low

₹618/118

Stock P/E

56.6

ROE8.86%
ROCE12.8%
Book Value₹109
Face Value₹1.00
Dividend Yield0.24%

About

Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days246280251346293334273234243241235229
Inventory Days5859611008993121968610986118
Days Payable130941398850869689886664103
Cash Conversion Cycle173245173357332342298241241283257244
Working Capital Days183207335452336401322258300294257274
ROCE %24%23%19%15%19%18%12%14%13%11%9%13%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 1:43

Designed & Shipped by Harshit Bansal